David Michael Waterhouse

机构：The US Oncology Network, Oncology Hematology Care · ORCID：0000-0001-5589-9939

发表论文 295 篇 · 总被引 22385 次 · h-index 48

代表论文

• State of Geographic Access to Cancer Treatment Trials in the United States: Are Studies Located Where Patients Live? (2024 · JCO Oncology Practice · 被引 39)
• A call to action to advance patient‐focused and decentralized clinical trials (2024 · Cancer · 被引 26)
• Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation (2024 · Lung Cancer · 被引 20)
• Real-World Evaluation of Treatment Patterns, Healthcare Costs, and Healthcare Resource Utilization Among Patients with Non-small Cell Lung Cancer in the US Receiving Sotorasib (2024 · Advances in Therapy · 被引 6)
• Matching-Adjusted Indirect Comparison of Sotorasib Versus Adagrasib in Previously Treated Advanced/Metastatic Non-Small Cell Lung Cancer Harboring KRAS G12C Mutation (2025 · Advances in Therapy · 被引 5)
• Real-World Treatment Patterns, Healthcare Resource Utilization, and Healthcare Costs in the First-Line Treatment of Metastatic Non-Small Cell Lung Cancer in the US (2025 · Current Oncology · 被引 5)